| Log in
Sun Pharmaceutical Industries Ltd

Sun Pharma to buy remaining 34% of Taro for $592M

05 September, 2012

Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has reached an agreement to buy out the minority shareholders of New York Stoc ....

To read the Full Story

Covering India’s Investment Ecosystem

subscribe

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Sun Pharma scraps plan to take NYSE-listed Taro private

Sun Pharma scraps plan to take NYSE-listed Taro private

TEAM VCC 5 years ago
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by...
Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M

TEAM VCC 5 years ago
Mumbai-based Sun Pharma Industries Ltd, India’s largest pharmaceutical company...
Takeover Battle Ends: Sun Pharma Takes Controlling Stake In Taro

Takeover Battle Ends: Sun Pharma Takes Controlling Stake In Taro

Reghu Balakrishnan 7 years ago
Putting an end to the long takeover battle between with Israeli firm Taro...
No Comments

Sun Pharma to buy remaining 34% of Taro for $592M

Powered by WordPress.com VIP